IFF and Master Perfumer Carlos Benaim Celebrate 50 Years Together
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171114006629/en/
Carlos Benaim (Photo: Business Wire)
International Flavors & Fragrances Inc. (NYSE: IFF) (Euronext Paris: IFF), a leading innovator of sensory experiences that move the world, is honoring the 50th anniversary of its Master Perfumer, Carlos Benaim with a series of celebrations throughout the next year.
“It is impossible to overstate the importance of Carlos’ contributions not only to IFF, but to the whole industry,” said Andreas Fibig, IFF Chairman and CEO. “The history of perfumery over the last 50 years has been shaped in many ways by the hand of Carlos Benaim. I consider it our greatest fortune that he chose to make his career with IFF.”
Born in Morocco and the son of a pharmacist, Mr. Benaim was intrigued by the botanicals and essential oils used in his father’s business. He studied chemistry at the University of Toulouse and Ecole Nationale Superíeure de Chimie de Toulouse in France. After answering an ad for a position at IFF in 1967, his year of training culminated with an apprenticeship with the legendary perfumer Ernest Shiftan – the “father of perfumery” at IFF – and later, trained with Bernard Chant. In the ensuing years, Mr. Benaim created hundreds of iconic fragrances for men and women, nine of which won the industry’s highest honor – the Fragrance Foundation Award. In 2002, he received a Lifetime Achievement Award from the American Society of Perfumers and in 2014, he was recognized by the Fragrance Foundation with a Perfumer of the Year Lifetime Achievement Award. In 2013, he was named IFF’s first-ever Master Perfumer in recognition of his creativity, mastery of his art, market success, and exceptional customer relationships.
Nicolas Mirzayantz, Group President, Fragrances, said, “Carlos, a true gentleman in every sense of the word, is also a genius of perfumery who has selflessly shared his knowledge by coaching, mentoring, and inspiring countless perfumers over the years. A master of natural ingredients, Carlos is at the cutting edge of his creativity and innovation and I’m excited, as always, to see what successful and iconic fragrances he will create for us – and our customers – in the future. His passion for his art, the industry, and our customers is unparalleled. Beyond the extraordinary pleasure of having Carlos as my colleague, I am also proud to call him a dear and lifelong friend.”
Mr. Benaim’s creations and co-creations include Polo Green and Polo Blue by Ralph Lauren; Euphoria by Calvin Klein; Eternity for Men by Calvin Klein; Herrera for Men by Carolina Herrera; Solo by Loewe; White Diamonds by Elizabeth Taylor; Fierce by Abercrombie & Fitch; Jasmin Noir by Bulgari; Very Irresistible Givenchy by Givenchy; Prada Amber by Prada; Armani Code for Women by Giorgio Armani; Flowerbomb, Spicebomb, and Antidote by Viktor & Rolf; Eau De Magnolia by Carlos Benaim for Frederic Malle; and many others.
Mr. Benaim reflected, “I want to talk not about what I did for IFF, but what IFF did for me. IFF trained me to be a perfumer, opened the doors of the major customers worldwide, and helped at every step along my path toward a successful international career. IFF gave me creative freedom. Fifty years later, with all the clarity of hindsight, I know that finding IFF was one of the luckiest accidents of my life.”
International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for exploration drives us to co-create unique products that consumers taste, smell, or feel in fine fragrances and beauty, detergents and household goods, as well as beloved foods and beverages. Our 7,400 team members globally take advantage of leading consumer insights, research and development, creative expertise, and customer intimacy to develop differentiated offerings for consumer products. Learn more at www.iff.com, Twitter , Facebook, Instagram, and LinkedIn.
International Flavors & Fragrances Inc.
Michael DeVeau, 212-708-7164
VP, Corporate Strategy, Investor Relations & Communications
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Visa Strengthens Commitment to Growing Digital Payments in India16.11.2018 14:33 | Pressemelding
Visa (NYSE: V) today announced a minority investment in BillDesk, a leading platform for online payments and bill payments in India. Visa’s investment and collaboration will help BillDesk develop new product lines for its payments and loyalty businesses and also expand its footprint into other geographies. The investment will be subject to necessary statutory approvals and is expected to have no direct bearing on Visa’s existing Indian business. “As a leading payments player in India, BillDesk has been a long time business partner to Visa. Having worked with BillDesk’s founders over the years, the Visa leadership has been consistently impressed with their vision, market knowledge and execution capabilities, as well as alignment on values. This investment further reinforces our long-term commitment to India’s digital payments growth story,” said Asia Pacific regional president, Chris Clark. “We are truly excited by this investment from the world's largest global payment network, Visa. W
Guidewire Enhances PartnerConnect Consulting Program with Addition of Product and Regional Specializations16.11.2018 13:55 | Pressemelding
Guidewire Software, Inc. (NYSE: GWRE), provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced the addition of specializations to its PartnerConnect Consulting program. Specializations have been added to aid insurance companies in selecting the best partner to lead or staff their Guidewire projects. Guidewire unveiled new specializations, including two which have been successfully piloted earlier this year. “Our customers will now have more clarity and information as to which partners have the proven capabilities in their chosen product and region,” said Lisa Walsh, vice president, Alliances, Guidewire Software. “Adding these specializations will also allow us to have more insight into a partner’s performance and competencies.” To earn a specialization, partners need to demonstrate skills, knowledge, and competency in a specific Guidewire product or solution by certifying staff at multiple levels (specialist and professional) through Guidewire’
Janssen receives positive CHMP opinion for ERLEADA™ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer who are at high risk of developing metastatic disease16.11.2018 13:15 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for apalutamide, a next generation oral androgen receptor inhibitor for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.2 The CHMP’s positive opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the use of apalutamide. The CHMP’s positive opinion is based on data from the pivotal SPARTAN Phase 3 clinical study which assessed the safety and efficacy of apalutamide versus placebo in patients with nmCRPC who have a rapidly rising prostate specific antigen (PSA) level despite receiving continuous androgen deprivation therapy (ADT). The SPARTAN clinical study showed that apalutamide, when added to ADT, significantly reduced the risk
Vertex Receives European CHMP Positive Opinion for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease16.11.2018 12:57 | Pressemelding
Vertex Pharmaceuticals (Europe) Limited today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, lumacaftor/ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF for patients aged 2 to 5 years old who have two copies of the F508del mutation. “Cystic fibrosis is a chronic, progressive disease and it is important to treat early to ensure the best possible outcomes for patients,” said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. “Today’s announcement brings us one step cl
Dimension Data Global Delivery Centre (GDC) in Prague wins the ABSL 2018 Diamond Award for Business Innovation16.11.2018 08:00 | Pressemelding
Dimension Data, the USD 8 billion global technology integrator and managed services provider, today announced that its Global Delivery Centre (GDC) in Prague has won the 2018 ABSL Diamond award for Business Innovation. The main purpose of this centre is to provide innovative, global service delivery capabilities and deep technical expertise to support our clients. The ABSL Diamond awards recognise companies that implement innovative projects, enhancing their business and strengthening the position of the business services sector. Every year, the aim is to identify successful activities in this sector and promote best practices, ultimately encouraging and inspiring others to follow suit. The ABSL celebrates initiatives that push business services forward and stand out as exemplary projects. Bill Padfield, Group Chief Operating Officer for Transformation and Services at Dimension Data, said: “Winning another award for our Support Services is a fantastic achievement. This time the ABSL Di
FCC Grants LeoSat U.S. Market Access16.11.2018 06:00 | Pressemelding
LeoSat Enterprises, the dynamic young company which is launching a unique new data network comprised of a constellation of up to 108 low-earth-orbit communications satellites, has been awarded the authority by the U.S. Federal Communications Commission (FCC) to provide NGSO (non-geostationary satellite orbit) services in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181115005890/en/ LeoSat's Global Business Backbone in Space (Graphic: Business Wire) The increasing demand for business connectivity and with it, the need to move large quantities of data quickly and securely around the world, is fast outpacing the infrastructure in place to carry it. Existing networks are already carrying more than 1 Zeta Byte of traffic globally and this is set to grow exponentially. The FCC market access grant will allow LeoSat to address currently unmet demand for high-bandwidth, low-latency, high-security data transmissio